Minister for Science and Technology highlighted that India’s Bioeconomy is projected to grow to $1 trillion by 2047 | Current Affairs | Vision IAS

Upgrade to Premium Today

Start Now
MENU
Home
Quick Links

High-quality MCQs and Mains Answer Writing to sharpen skills and reinforce learning every day.

Watch explainer and thematic concept-building videos under initiatives like Deep Dive, Master Classes, etc., on important UPSC topics.

A short, intensive, and exam-focused programme, insights from the Economic Survey, Union Budget, and UPSC current affairs.

ESC

In Summary

  • India's bioeconomy is projected to reach $1 trillion by 2047, growing from $10 billion in 2014 to $195.3 billion in 2025, contributing 4.8% to GDP.
  • Key growth drivers include 20% ethanol blending, advancements in biopharmaceuticals, new Global Capability Centers, and industrial use of enzymes and microbes.
  • Initiatives like the BioE3 Policy, BioPharma SHAKTI Programme, and a ₹1 lakh crore RDI Fund support innovation and infrastructure in the sector.

In Summary

Addressing the International conference, the Union Minister focused on bioeconomy-led growth and the sector projected to grow to $1 trillion by 2047.

  • Bioeconomy is "the production, use and conservation of biological resources, including related knowledge, science, technology, and innovation to provide information, products, processes and services to all economic sectors with the aim of moving towards a sustainable economy". 

Achievements of India’s Bioeconomy 

  • Sector Growth: $10 billion (2014) to $195.3 billion (2025), contributing 4.8% to GDP.
    • Increase in Start-Ups: From 50 (2014) to 11,855 (2025).
  • Lower Current Account Deficit: $12-14 billion savings in foreign exchange due to reduction in petrol imports.
  • Growth Drivers: 20% blending of ethanol in petrol, consumption of GLP-1 class of drugs, opening of dozens of new Global Capability Centers (GCCs), and usage of enzymes and microbes in industrial sectors like textiles, detergents, food processing, biofuels etc.
  • Research and Innovation: Development of world’s first DNA COVID-19 vaccine (ZyCoV-D), indigenous CAR-T cell therapy, mRNA vaccine platforms, India’s first indigenously developed antibiotic (Nafithromycin), establishment of a National Biobank.

Key Initiatives Promoting Bioeconomy in India

  • BioE3 (Biotechnology for Economy, Environment and Employment) Policy: Includes initiatives such as advanced biomanufacturing facilities, bio-foundry clusters, and bio-AI hubs.
  • BioPharma SHAKTI Programme: To enhance India’s capabilities in next-generation biopharmaceuticals and expand clinical research infrastructure.
  • Research, Development and Innovation (RDI) Fund: ₹1 lakh crore fund to support deep-tech innovation including biotechnology.
  • Biotechnology Industry Research Assistance Council (BIRAC): Not-for-profit Section 8, Schedule B, Public Sector Enterprise under Department of Biotechnology. 
    • Its initiatives include National Biopharma Mission (NBM)-Innovate in India (i3), Biotechnology Ignition Grant (BIG), Small Business Innovation Research Initiative (SBIRI), Biotechnology Industry Partnership Programme (BIPP) etc.
Watch Video News Today

Explore Related Content

Discover more articles, videos, and terms related to this topic

RELATED VIDEOS

3
News Today (Aug 15-16, 2024)

News Today (Aug 15-16, 2024)

YouTube HD
Circularity in Textile Structure

Circularity in Textile Structure

YouTube HD
Weekly Focus | India's Natural Wealth

Weekly Focus | India's Natural Wealth

YouTube HD

RELATED TERMS

3

National Biopharma Mission (NBM)-Innovate in India (i3)

A collaborative initiative aimed at fostering innovation and R&D in the biopharmaceutical sector, encouraging indigenous development of new drugs and biologics.

Biotechnology Industry Research Assistance Council (BIRAC)

A Public Sector Undertaking (PSU) set up by the Department of Biotechnology (DBT) to foster innovation and entrepreneurship in the biotechnology sector. It provides financial and technical support to startups and research institutions.

BioPharma SHAKTI Programme

A program designed to enhance India's capabilities in advanced biopharmaceuticals and expand clinical research infrastructure, aiming to bolster the biopharmaceutical sector.

Title is required. Maximum 500 characters.

Search Notes

Filter Notes

Loading your notes...
Searching your notes...
Loading more notes...
You've reached the end of your notes

No notes yet

Create your first note to get started.

No notes found

Try adjusting your search criteria or clear the search.

Saving...
Saved

Please select a subject.

Referenced Articles

linked

No references added yet